Board of Trustees

The Board of Trustees is composed of proven leaders from the world’s business and non-profit communities who bring a range of skills and perspectives to the Institute. They are committed to science, innovation, high-quality research and supporting the Institute’s mission. Trustees are charged with monitoring Institute operations to ensure the organization fulfills its scientific and training efforts, while operating in a financially responsible manner.

Daniel C. Lewis (Chair)

Former President

Booz Allen HamiltonCalifornia

Richard A. Heyman, PhD (Vice Chair)

Salk Alumnus Executive Chairman

MetacrineCalifornia

Marna C. Whittington, PhD (Vice Chair)

(Retired) Chief Executive Officer

Allianz Global Investors CapitalDelaware

Donald Cohn

Cohn EnterprisesCalifornia

David Dolby

Director

Dolby Family Ventures, LPCalifornia

Frederick J. Dotzler

Managing Director

De Novo VenturesCalifornia

Jay Flatley

Executive Chairman

IlluminaCalifornia

Rusty Gage

President

Laboratory of Genetics Vi and John Adler Chair for Research on Age-Related Neurodegenerative DiseaseSalk InstituteCalifornia